Filing Details

Accession Number:
0001562180-17-001461
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-04-04 21:41:17
Reporting Period:
2017-03-31
Filing Date:
2017-04-04
Accepted Time:
2017-04-04 21:41:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1100412 Array Biopharma Inc ARRY Pharmaceutical Preparations (2834) 841460811
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1191818 Kyle Lefkoff C/O Boulder Ventures
1941 Pearl Street, Suite 300
Boulder CO 80302
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-11-28 2,000 $0.00 6,585 No 5 G Direct
Common Stock Acquisiton 2017-03-31 25,000 $3.69 31,585 No 4 M Direct
Common Stock Acquisiton 2017-03-31 20,000 $4.36 51,585 No 4 M Direct
Common Stock Disposition 2017-03-31 45,000 $8.92 6,585 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 G Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2017-03-31 25,000 $0.00 25,000 $3.69
Common Stock Stock Option Disposition 2017-03-31 20,000 $0.00 20,000 $4.36
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2022-04-25 No 4 M Direct
0 2013-10-24 2022-10-24 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 45,000 Indirect See footnote
Footnotes
  1. The price reported for these shares is the weighted average sale price. Details of actual prices for shares sold are available from the Issuer upon request.
  2. Comprised of 30,000 shares of common stock in trust for the benefit of Mr. Lefkoff's minor children and 15,000 shares of common stock held by BV Partners III Profit Sharing account for the benefit of Mr. Lefkoff.
  3. The option vested in 2 equal annual installments beginning on April 25, 2013.